gemfibrozil and enclomiphene

gemfibrozil has been researched along with enclomiphene in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Ertuğrul, O; Yaşar, HY	1

Other Studies

2 other study(ies) available for gemfibrozil and enclomiphene

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Clomiphene citrate-induced severe hypertriglyceridemia. Fertility and sterility, 2009, Volume: 92, Issue:1 Topics: Adult; Cholesterol; Cholesterol, HDL; Clomiphene; Estrogen Antagonists; Female; Gemfibrozil; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins, LDL; Polycystic Ovary Syndrome	2009

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Clomiphene citrate-induced severe hypertriglyceridemia.

Fertility and sterility, 2009, Volume: 92, Issue:1

Topics: Adult; Cholesterol; Cholesterol, HDL; Clomiphene; Estrogen Antagonists; Female; Gemfibrozil; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins, LDL; Polycystic Ovary Syndrome

2009